Mestag Therapeutics
Innovative therapy provider for cancer and inflammatory disease targeting fibroblast-immune interactions.
2
Funding Rounds
$13.0m
Money raised
Funding series
Funding Series Analysis
The company Mestag Therapeutics has raised a total of $11m in funding over 2 rounds.
Key Insights:
- Mestag Therapeutics April 2021 Seed Funding Round: $11m
- Mestag Therapeutics Grant Funding Round, August 2024: $2m
Mestag Therapeutics April 2021 Seed Funding Round
$11m
Mestag Therapeutics Grant Funding Round, August 2024
$2m
Industries
Mestag Therapeutics is active in the following industries: